Trial Profile
Characterization and Research of Predictive Markers of Neurotoxicity During Treatment With Oxaliplatin in Colorectal Carcinoma: a Genetic and Proteomic Approach. Phase II Multicenter Study.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 24 Jan 2020
Price :
$35
*
At a glance
- Drugs Oxaliplatin (Primary) ; Fluorouracil; Folinic acid
- Indications Carcinoma; Colorectal cancer
- Focus Biomarker; Pharmacodynamics; Pharmacogenomic
- Acronyms NEUROTOXALI
- 14 Jun 2012 Additional lead trial investigator (Paice) identified as reported by Robert H. Lurie Comprehensive Cancer Center record.
- 12 Mar 2012 Additional lead trial investigator (Maxwell Vergo) identified as reported by Robert H. Lurie Comprehensive Cancer Center record.
- 12 Mar 2012 New source identified and integrated (Robert H. Lurie Comprehensive Cancer Center, Northwestern University; NU10CC05).